Literature DB >> 3886230

In vivo localization of C3 on the brush border of proximal tubules of kidneys from nephrotic patients.

G Camussi, P Stratta, G Mazzucco, M Gaido, C Tetta, R Castello, M Rotunno, A Vercellone.   

Abstract

Deposits of C3 but not of C1q and C4 were detected on the proximal tubules of kidneys from nephrotic patients with non-selective proteinuria. The incidence of tubular C3 deposits was significantly higher in patients with membranous glomerulonephritis, focal glomerulosclerosis, membrano-proliferative glomerulonephritis and non-selective proteinuria than in patients with minimal change disease, nephrotic syndrome and selective proteinuria or in patients with glomerular disease, but without nephrotic syndrome. The occurrence of tubular C3 deposits was positively correlated with the amount of urinary C3 excretion. In vitro studies showed that the human normal kidney as well as pathologic specimens negative for in vivo tubular C3 deposits were able to bind C3 on the brush border of proximal tubules when incubated with fresh heterologous serum. In contrast, in patients with non-selective proteinuria and in vivo tubular C3 deposits, the binding of heterologous C3 to the brush border of proximal tubules was markedly reduced. The positive correlation between the occurrence of tubular C3 deposits and the urinary complement excretion, together with the detection of the C3 breakdown products in the urines further supported the hypothesis that complement components, once filtrated through the glomerular barrier, might be activated by the brush border of the proximal tubule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886230

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  11 in total

Review 1.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

2.  C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis.

Authors:  Runhong Han; Shuai Hu; Weisong Qin; Jinsong Shi; Qin Hou; Xia Wang; Xiaodong Xu; Minchao Zhang; Caihong Zeng; Zhihong Liu; Hao Bao
Journal:  JCI Insight       Date:  2019-04-04

Review 3.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

4.  Specific increases in urinary excretion of anti-DNA antibodies in lupus mice induced by lysozyme administration: further evidence for DNA-anti-DNA immune complexes in the pathogenesis of nephritis.

Authors:  T Yamamoto; M Nagase; A Hishida; N Honda
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

5.  Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease.

Authors:  Azadeh Zaferani; Romain R Vivès; Pieter van der Pol; Jelleke J Hakvoort; Gerjan J Navis; Harry van Goor; Mohamed R Daha; Hugues Lortat-Jacob; Marc A Seelen; Jacob van den Born
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

6.  Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.

Authors:  Mauro Abbate; Carla Zoja; Daniela Corna; Daniela Rottoli; Cristina Zanchi; Nadia Azzollini; Susanna Tomasoni; Silvia Berlingeri; Marina Noris; Marina Morigi; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 10.121

7.  Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Authors:  Marta Martin-Lorenzo; Laura Gonzalez-Calero; Paula J Martinez; Montserrat Baldan-Martin; Juan Antonio Lopez; Gema Ruiz-Hurtado; Fernando de la Cuesta; Julián Segura; Jesús Vazquez; Fernando Vivanco; Maria G Barderas; Luis M Ruilope; Gloria Alvarez-Llamas
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

8.  Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.

Authors:  Tomas Vaisar; Blythe Durbin-Johnson; Kathryn Whitlock; Ilona Babenko; Rajnish Mehrotra; David M Rocke; Maryam Afkarian
Journal:  Diabetes Care       Date:  2018-08-27       Impact factor: 19.112

Review 9.  Complement in glomerular injury.

Authors:  Stefan P Berger; Mohamed R Daha
Journal:  Semin Immunopathol       Date:  2007-09-28       Impact factor: 9.623

10.  Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.

Authors:  Rosa G M Lammerts; Ditmer T Talsma; Wendy A Dam; Mohamed R Daha; Marc A J Seelen; Stefan P Berger; Jacob van den Born
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.